1. Hayduchok I.G., Shapovalova V.O., Shapovalov V.V., Shapovalov V.V. Control regime of antibacterial drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with dual disorders. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. Kyiv: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020. N. 230–2020. 6 p.
2. Hayduchok I. G., Shapovalova V. O., Shapovalov V. V., Shapovalov V. V. Control regime of drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with systemic diseases. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020. N. 225 – 2020. 6 p.
3. Beketova TV, Blank LM, Lila AM. COVID-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab) // Rheumatology Science and Practice. 2019. Retrieved from https://rsp.mediar-press.net/rsp/article/view/2889?locale=ru_RU#
4. Hayduchok I. Pharmacotherapy of immunopathological syndromes among patients with systemic lupus erythematosus based on ABC/VEN analysis // Acta Scientific Medical Science. 2021. Vol. 5, Iss. 6. P. 67-73. DOI: 10.31080/ASMS2020.05.0925
5. Hayduchok I. G., Shapovalova V. O., Shapovalov (Jr.) V. V. Shapovalov V.V. Control regime of drugs for pharmacotherapy vasculitis of Shenlein-Genoch: An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine, 2021. N. 64–2021. 7 p.